Tenax presents LEVEL clinical trial results at Cantor conference; data not in filing text

TENAX THERAPEUTICS, INC.

Tenax Therapeutics (TENX) presented at 2026 Cantor Global Healthcare Conference on Sept 9, 2026.
Presentation titled 'LEVEL Clinical Trial Results' was published on company website and attached as Exhibit 99.1.
Filing text contains only the presentation title slide; actual trial results are not included in the 8-K text.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.